In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.
Some have defended cutbacks to the United States Postal Service, weeks ahead of the election, by citing the USPS’s financial struggles. But the postal service was created to provide a public service, writes Yale SOM’s Jeffrey Sonnenfeld, not to turn a profit.
With the Democratic National Convention taking place online, Prof. Jeffrey Sonnenfeld reflects on other conventions Americans have abandoned, and the traditions we’ve let go of, during this tumultuous time.
With proper precautions, the risk of a day at work, a ride on the bus, or a workout at the gym may be acceptable, write Yale SOM’s Arthur J. Swersey and his co-authors. But that risk compounds dramatically when an activity is repeated day after day.
Why did the stock market recover as the economy suffered? Yale SOM’s Shyam Sunder points to the hundreds of billions of dollars injected into the economy by the Federal Reserve and other central banks.
The devastating mental health consequences of working on the front lines of the COVID-19 pandemic are already becoming apparent. Yale SOM’s Julia DiBenigno and Harvard’s Michaela Kerrissey propose assigning dedicated mental health personnel to frontline medical units.
The Trump administration is reportedly planning to limit immigration for skilled workers in order to boost employment for domestic workers. Yale SOM’s Jeffrey Sonnenfeld writes that such a move would stifle innovation and even endanger Americans’ health.